160 related articles for article (PubMed ID: 21658384)
1. Tailoring elastase inhibition with synthetic peptides.
Vasconcelos A; Azoia NG; Carvalho AC; Gomes AC; Güebitz G; Cavaco-Paulo A
Eur J Pharmacol; 2011 Sep; 666(1-3):53-60. PubMed ID: 21658384
[TBL] [Abstract][Full Text] [Related]
2. A selective reversible azapeptide inhibitor of human neutrophil proteinase 3 derived from a high affinity FRET substrate.
Epinette C; Croix C; Jaquillard L; Marchand-Adam S; Kellenberger C; Lalmanach G; Cadene M; Viaud-Massuard MC; Gauthier F; Korkmaz B
Biochem Pharmacol; 2012 Mar; 83(6):788-96. PubMed ID: 22209715
[TBL] [Abstract][Full Text] [Related]
3. Development of a highly water-soluble peptide-based human neutrophil elastase inhibitor; AE-3763 for treatment of acute organ injury.
Inoue Y; Omodani T; Shiratake R; Okazaki H; Kuromiya A; Kubo T; Sato F
Bioorg Med Chem; 2009 Nov; 17(21):7477-86. PubMed ID: 19811924
[TBL] [Abstract][Full Text] [Related]
4. Protein matrices for improved wound healing: elastase inhibition by a synthetic peptide model.
Vasconcelos A; Pêgo AP; Henriques L; Lamghari M; Cavaco-Paulo A
Biomacromolecules; 2010 Sep; 11(9):2213-20. PubMed ID: 20690591
[TBL] [Abstract][Full Text] [Related]
5. Autoprocessing of neutrophil elastase near its active site reduces the efficiency of natural and synthetic elastase inhibitors.
Dau T; Sarker RS; Yildirim AO; Eickelberg O; Jenne DE
Nat Commun; 2015 Apr; 6():6722. PubMed ID: 25857284
[TBL] [Abstract][Full Text] [Related]
6. [Bowman-Birk soy inhibitor as an affinity ligand for isolating leukocyte elastase. Inhibition of elastin hydrolysis, catalyzed by leukocyte elastase].
Tikhonova TV; Larionova NI; Gladysheva IP; Kazanskaia NF
Biokhimiia; 1993 Nov; 58(11):1669-76. PubMed ID: 8268308
[TBL] [Abstract][Full Text] [Related]
7. Cinnoline derivatives as human neutrophil elastase inhibitors.
Giovannoni MP; Schepetkin IA; Crocetti L; Ciciani G; Cilibrizzi A; Guerrini G; Khlebnikov AI; Quinn MT; Vergelli C
J Enzyme Inhib Med Chem; 2016 Aug; 31(4):628-39. PubMed ID: 26194018
[TBL] [Abstract][Full Text] [Related]
8. Interaction of human leukocyte elastase with plasma fibronectin and its inhibition by soybean Bowman-Birk protease inhibitor.
Larionova NI; Balabushevitch NG; Zhatikov PA
Biochemistry (Mosc); 1998 Sep; 63(9):1078-82. PubMed ID: 9795279
[TBL] [Abstract][Full Text] [Related]
9. Natural compounds as inhibitors of human neutrophil elastase.
Siedle B; Hrenn A; Merfort I
Planta Med; 2007 May; 73(5):401-20. PubMed ID: 17447201
[TBL] [Abstract][Full Text] [Related]
10. Role of the P6-P3' region of the serpin reactive loop in the formation and breakdown of the inhibitory complex.
Plotnick MI; Schechter NM; Wang ZM; Liu X; Rubin H
Biochemistry; 1997 Nov; 36(47):14601-8. PubMed ID: 9398179
[TBL] [Abstract][Full Text] [Related]
11. The role of threonine in the P2 position of Bowman-Birk proteinase inhibitors: studies on P2 variation in cyclic peptides encompassing the reactive site loop.
McBride JD; Brauer AB; Nievo M; Leatherbarrow RJ
J Mol Biol; 1998 Sep; 282(2):447-58. PubMed ID: 9735299
[TBL] [Abstract][Full Text] [Related]
12. The full-length cDNA of anticoagulant protein infestin revealed a novel releasable Kazal domain, a neutrophil elastase inhibitor lacking anticoagulant activity.
Lovato DV; Nicolau de Campos IT; Amino R; Tanaka AS
Biochimie; 2006 Jun; 88(6):673-81. PubMed ID: 16469426
[TBL] [Abstract][Full Text] [Related]
13. Human neutrophil elastase phosphonic inhibitors with improved potency of action.
Winiarski Ł; Oleksyszyn J; Sieńczyk M
J Med Chem; 2012 Jul; 55(14):6541-53. PubMed ID: 22720718
[TBL] [Abstract][Full Text] [Related]
14. In vitro inhibition of human neutrophil elastase by oleic acid albumin formulations from derivatized cotton wound dressings.
Edwards JV; Howley P; Cohen IK
Int J Pharm; 2004 Oct; 284(1-2):1-12. PubMed ID: 15454291
[TBL] [Abstract][Full Text] [Related]
15. [High molecular weight soy isoinhibitors of the Bowman-Birk type. Isolation, characteristics, and kinetics of interaction with proteinases].
Gladysheva IP; Sharafutdinov TZ; Larionova NI
Bioorg Khim; 1994 Mar; 20(3):281-9. PubMed ID: 8166755
[TBL] [Abstract][Full Text] [Related]
16. [Inhibition of elastin hydrolysis, catalyzed by human leukocyte elastase and cathepsin G, by the Bowman-Birk type soy inhibitor].
Tikhonova TV; Gladysheva IP; Kazanskaia NF; Larionova NI
Biokhimiia; 1994 Nov; 59(11):1739-45. PubMed ID: 7873681
[TBL] [Abstract][Full Text] [Related]
17. Phosphonic pseudopeptides as human neutrophil elastase inhibitors--a combinatorial approach.
Sieńczyk M; Podgórski D; Błażejewska A; Kulbacka J; Saczko J; Oleksyszyn J
Bioorg Med Chem; 2011 Feb; 19(3):1277-84. PubMed ID: 21216608
[TBL] [Abstract][Full Text] [Related]
18. Characterization of potential elastase inhibitor-peptides regulated by a molecular switch for wound dressings applications.
Barros SC; Martins JA; Marcos JC; Cavaco-Paulo A
Enzyme Microb Technol; 2012 Feb; 50(2):107-14. PubMed ID: 22226196
[TBL] [Abstract][Full Text] [Related]
19. Influence of secretory leukocyte protease inhibitor-based peptides on elastase activity and their incorporation in hyaluronic acid hydrogels for chronic wound therapy.
Barros SC; Martins JA; Marcos JC; Cavaco-Paulo A
Biopolymers; 2012; 98(6):576-90. PubMed ID: 23203763
[TBL] [Abstract][Full Text] [Related]
20. Peptide mimics of the Bowman-Birk inhibitor reactive site loop.
McBride JD; Watson EM; Brauer AB; Jaulent AM; Leatherbarrow RJ
Biopolymers; 2002; 66(2):79-92. PubMed ID: 12325158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
